Triglyceride-glucose index is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents - Zhu, Yong; Liu, Kesen; Chen, Maolin; Liu, Yan; Gao, Ang; Hu, Chengping; Li, Hong; Zhu, Huagang; Han, Hongya; Zhang, Jianwei; Zhao, Yingxin (Cardiovascular diabetology, 2021)
Keywords: Acute coronary syndrome; Acute Coronary Syndrome - blood; Acute Coronary Syndrome - diagnostic imaging; Acute Coronary Syndrome - epidemiology; Acute Coronary Syndrome - therapy; Acute coronary syndromes; Aged; Angiography; Angioplasty; Arteriosclerosis; Atherosclerosis; Beijing - epidemiology; Biomarkers - blood; Blood Glucose - metabolism; Body mass index; Cardiovascular disease; Cardiovascular diseases; Coronary Angiography; Coronary Restenosis - blood; Coronary Restenosis - diagnostic imaging; Coronary Restenosis - epidemiology; Coronary vessels; Disease prevention; Drug delivery; Drug-eluting stents; Fasting; Female; Glucose; Humans; Hypertension; Implants; In-stent restenosis; Insulin; Insulin Resistance; Laboratory testing; Male; Medical imaging; Metabolism; Middle Aged; Original Investigation; Percutaneous coronary intervention; Percutaneous Coronary Intervention - adverse effects; Prediction models; Predictive Value of Tests; Prevalence; Reclassification; Regression analysis; Restenosis; Retrospective Studies; Risk Assessment; Risk Factors; Statistical analysis; Stents; Time Factors; Treatment Outcome; Triglyceride-glucose index; Triglycerides - blood; Uric acid; Beijing; Beijing China; China; Triglyceride-glucose index; In-stent restenosis; Insulin resistance; Percutaneous coronary intervention; Acute coronary syndrome; Drug-eluting stents